HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nagalakshmi Nadiminty Selected Research

NF-kappa B p52 Subunit

4/2010Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.
2/2010Microarray analysis reveals potential target genes of NF-kappaB2/p52 in LNCaP prostate cancer cells.
12/2008NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation.
7/2007LIGHT, a member of the TNF superfamily, activates Stat3 mediated by NIK pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nagalakshmi Nadiminty Research Topics

Disease

34Prostatic Neoplasms (Prostate Cancer)
12/2017 - 07/2005
21Neoplasms (Cancer)
03/2022 - 02/2005
2Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 05/2007
2Melanoma (Melanoma, Malignant)
05/2007 - 02/2005
1Infertility (Sterility)
06/2022
1Urinary Bladder Neoplasms (Bladder Cancer)
03/2022
1Kidney Neoplasms (Kidney Cancer)
01/2021
1Carcinogenesis
01/2012
1Bone Resorption
06/2008
1Inflammation (Inflammations)
07/2007
1Lymphoma (Lymphomas)
05/2007
1Ovarian Neoplasms (Ovarian Cancer)
05/2007
1Hyperplasia
05/2006
1Neoplasm Metastasis (Metastasis)
03/2006
1Osteosarcoma (Osteogenic Sarcoma)
03/2006
1Breast Neoplasms (Breast Cancer)
04/2005
1Lung Neoplasms (Lung Cancer)
04/2005

Drug/Important Bio-Agent (IBA)

20Androgen Receptors (Androgen Receptor)IBA
12/2017 - 07/2005
16AndrogensIBA
04/2016 - 07/2005
7enzalutamideIBA
12/2017 - 08/2013
5Interleukin-6 (Interleukin 6)IBA
08/2014 - 05/2007
4Androgen Antagonists (Antiandrogens)IBA
01/2017 - 07/2006
4NF-kappa B p52 SubunitIBA
04/2010 - 07/2007
4SeleniumIBA
11/2008 - 04/2005
3Pharmaceutical PreparationsIBA
06/2014 - 03/2010
3Docetaxel (Taxotere)FDA Link
06/2014 - 03/2013
3SurvivinIBA
01/2012 - 07/2007
3Prostate-Specific Antigen (Semenogelase)IBA
07/2006 - 03/2006
2Poly(ADP-ribose) Polymerase InhibitorsIBA
03/2022 - 01/2021
2NiclosamideFDA Link
01/2017 - 06/2014
2Small Interfering RNA (siRNA)IBA
04/2015 - 03/2013
2MicroRNAs (MicroRNA)IBA
01/2012 - 01/2012
2AlkaloidsIBA
01/2012 - 03/2010
2sanguinarineIBA
01/2012 - 03/2010
2andrographolideIBA
02/2011 - 08/2010
2Interleukin-4 (Interleukin 4)IBA
02/2009 - 07/2005
2NF-kappa B (NF-kB)IBA
05/2006 - 07/2005
2LigandsIBA
03/2006 - 04/2005
1Biomarkers (Surrogate Marker)IBA
06/2022
1Cisplatin (Platino)FDA LinkGeneric
03/2022
1PlatinumIBA
03/2022
1olaparibIBA
01/2021
1niraparibIBA
01/2021
1talazoparibIBA
01/2021
1veliparibIBA
01/2021
1rucaparibIBA
01/2021
1QuercetinIBA
12/2017
1RNA Splicing FactorsIBA
12/2017
1bicalutamide (Casodex)FDA LinkGeneric
01/2017
1Dehydroepiandrosterone (DHEA)IBA
04/2015
1ProgesteroneFDA LinkGeneric
04/2015
1Indomethacin (Indometacin)FDA LinkGeneric
04/2015
1SteroidsIBA
04/2015
1CholesterolIBA
04/2015
1abirateroneIBA
04/2015
1Glucose (Dextrose)FDA LinkGeneric
06/2014
1Guanine Nucleotide Dissociation Inhibitors (GDIs)IBA
11/2013
1Biological ProductsIBA
09/2013
1flavoneIBA
09/2013
1ApigeninIBA
09/2013
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2012
1DiterpenesIBA
08/2010
1LactonesIBA
08/2010
1Antineoplastic Agents (Antineoplastics)IBA
03/2010
1Paclitaxel (Taxol)FDA LinkGeneric
03/2010
1Testosterone (Sustanon)FDA Link
08/2009
1EnzymesIBA
08/2009
1MicronutrientsIBA
11/2008
1RANK LigandIBA
06/2008
1Charcoal (Charbon)IBA
09/2007
1Cyclin D1IBA
07/2007
1CytokinesIBA
07/2007
1Proteins (Proteins, Gene)FDA Link
07/2007
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2007
1Oncogene Proteins (Oncogene Protein)IBA
07/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2007
1Growth InhibitorsIBA
05/2007
1methylselenic acidIBA
07/2006
1matrigelIBA
07/2006
1selenomethylselenocysteine (methylselenocysteine)IBA
07/2006
1Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
03/2006
1OsteoprotegerinIBA
03/2006
1Complementary DNA (cDNA)IBA
03/2006
1Serine Proteases (Serine Protease)IBA
03/2006
1CarcinogensIBA
04/2005
1Messenger RNA (mRNA)IBA
04/2005
1Estrogen ReceptorsIBA
04/2005
1Estrogens (Estrogen)FDA Link
04/2005
1Estrogen Receptor alphaIBA
04/2005
1Estrogen Receptor betaIBA
04/2005
1EugenolIBA
02/2005
1isoeugenolIBA
02/2005
1A 19IBA
02/2005
1E2F Transcription FactorsIBA
02/2005

Therapy/Procedure

19Castration
12/2017 - 02/2009
13Therapeutics
01/2017 - 02/2005
2Drug Therapy (Chemotherapy)
03/2022 - 03/2010
1Chemoprevention
11/2008
1Intraperitoneal Injections
07/2006